Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement.

Meeker DG, Cooper KB, Renard RL, Mears SC, Smeltzer MS, Barnes CL.

J Arthroplasty. 2019 Jul;34(7):1458-1461. doi: 10.1016/j.arth.2019.03.008. Epub 2019 Mar 12.

PMID:
30935799
2.

Erratum to 'General Assembly, Prevention, Antiseptic Irrigation Solution: Proceedings of International Consensus on Orthopedic Infections' [The Journal of Arthroplasty 34 (2019) S131-S138].

Blom A, Cho J, Fleischman A, Goswami K, Ketonis C, Kunutsor SK, Makar G, Meeker DG, Morgan-Jones R, Ortega-Peña S, Parvizi J, Smeltzer M, Stambough JB, Urish K, Ziliotto G.

J Arthroplasty. 2019 Jun;34(6):1299. doi: 10.1016/j.arth.2019.02.064. Epub 2019 Mar 28. No abstract available.

PMID:
30930156
3.

General Assembly, Prevention, Antiseptic Irrigation Solution: Proceedings of International Consensus on Orthopedic Infections.

Blom A, Cho J, Fleischman A, Goswami K, Ketonis C, Kunutsor SK, Makar G, Meeker DG, Morgan-Jones R, Ortega-Peña S, Parvizi J, Smeltzer M, Stambough JB, Urish K, Ziliotto G.

J Arthroplasty. 2019 Feb;34(2S):S131-S138. doi: 10.1016/j.arth.2018.09.063. Epub 2018 Oct 19. No abstract available. Erratum in: J Arthroplasty. 2019 Jun;34(6):1299.

PMID:
30348567
4.

Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.

Moon SH, Zhang X, Zheng G, Meeker DG, Smeltzer MS, Huang E.

J Med Chem. 2017 Dec 14;60(23):9630-9640. doi: 10.1021/acs.jmedchem.7b01064. Epub 2017 Nov 22.

PMID:
29136469
5.

Versatility of targeted antibiotic-loaded gold nanoconstructs for the treatment of biofilm-associated bacterial infections.

Meeker DG, Wang T, Harrington WN, Zharov VP, Johnson SA, Jenkins SV, Oyibo SE, Walker CM, Mills WB, Shirtliff ME, Beenken KE, Chen J, Smeltzer MS.

Int J Hyperthermia. 2018 Mar;34(2):209-219. doi: 10.1080/02656736.2017.1392047.

6.

Impact of Staphylococcus aureus regulatory mutations that modulate biofilm formation in the USA300 strain LAC on virulence in a murine bacteremia model.

Rom JS, Atwood DN, Beenken KE, Meeker DG, Loughran AJ, Spencer HJ, Lantz TL, Smeltzer MS.

Virulence. 2017 Nov 17;8(8):1776-1790. doi: 10.1080/21505594.2017.1373926. Epub 2017 Oct 4.

7.

Antibiotic-loaded phosphatidylcholine inhibits staphylococcal bone infection.

Jennings JA, Beenken KE, Skinner RA, Meeker DG, Smeltzer MS, Haggard WO, Troxel KS.

World J Orthop. 2016 Aug 18;7(8):467-74. doi: 10.5312/wjo.v7.i8.467. eCollection 2016 Aug 18.

8.

Could targeted, antibiotic-loaded gold nanoconstructs be a new magic bullet to fight infection?

Meeker DG, Chen J, Smeltzer MS.

Nanomedicine (Lond). 2016 Sep;11(18):2379-82. doi: 10.2217/nnm-2016-0260. Epub 2016 Aug 16. No abstract available.

9.

Synergistic Photothermal and Antibiotic Killing of Biofilm-Associated Staphylococcus aureus Using Targeted Antibiotic-Loaded Gold Nanoconstructs.

Meeker DG, Jenkins SV, Miller EK, Beenken KE, Loughran AJ, Powless A, Muldoon TJ, Galanzha EI, Zharov VP, Smeltzer MS, Chen J.

ACS Infect Dis. 2016 Apr 8;2(4):241-250. Epub 2016 Feb 10.

10.

Evaluation of Antibiotics Active against Methicillin-Resistant Staphylococcus aureus Based on Activity in an Established Biofilm.

Meeker DG, Beenken KE, Mills WB, Loughran AJ, Spencer HJ, Lynn WB, Smeltzer MS.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5688-94. doi: 10.1128/AAC.01251-16. Print 2016 Oct.

11.

Impact of sarA and Phenol-Soluble Modulins on the Pathogenesis of Osteomyelitis in Diverse Clinical Isolates of Staphylococcus aureus.

Loughran AJ, Gaddy D, Beenken KE, Meeker DG, Morello R, Zhao H, Byrum SD, Tackett AJ, Cassat JE, Smeltzer MS.

Infect Immun. 2016 Aug 19;84(9):2586-94. doi: 10.1128/IAI.00152-16. Print 2016 Sep.

12.

XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways.

Atwood DN, Beenken KE, Loughran AJ, Meeker DG, Lantz TL, Graham JW, Spencer HJ, Smeltzer MS.

Infect Immun. 2016 Mar 24;84(4):1214-1225. doi: 10.1128/IAI.01462-15. Print 2016 Apr.

13.

Regulatory Mutations Impacting Antibiotic Susceptibility in an Established Staphylococcus aureus Biofilm.

Atwood DN, Beenken KE, Lantz TL, Meeker DG, Lynn WB, Mills WB, Spencer HJ, Smeltzer MS.

Antimicrob Agents Chemother. 2016 Jan 11;60(3):1826-9. doi: 10.1128/AAC.02750-15.

14.

Comparative impact of diverse regulatory loci on Staphylococcus aureus biofilm formation.

Atwood DN, Loughran AJ, Courtney AP, Anthony AC, Meeker DG, Spencer HJ, Gupta RK, Lee CY, Beenken KE, Smeltzer MS.

Microbiologyopen. 2015 Jun;4(3):436-51. doi: 10.1002/mbo3.250. Epub 2015 Mar 21.

15.

NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Fu J, Rodova M, Nanta R, Meeker D, Van Veldhuizen PJ, Srivastava RK, Shankar S.

Neuro Oncol. 2013 Jun;15(6):691-706. doi: 10.1093/neuonc/not011. Epub 2013 Mar 12.

16.

Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.

Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK.

PLoS One. 2011 Jan 31;6(1):e16530. doi: 10.1371/journal.pone.0016530.

17.

Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.

Srivastava RK, Tang SN, Zhu W, Meeker D, Shankar S.

Front Biosci (Elite Ed). 2011 Jan 1;3:515-28.

18.

Supplemental Content

Loading ...
Support Center